Clinical Trial Update: Electrophysiological Biomarkers of AV-101 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on electrophysiological biomarkers for AV-101 in healthy volunteers; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• AV-101

Snippet

Sponsor: Marijn Lijffijt, PhD | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-17